2012
DOI: 10.2471/blt.12.113183
|View full text |Cite
|
Sign up to set email alerts
|

Phenobarbital: missing in action

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
24
0
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 32 publications
(25 citation statements)
references
References 10 publications
0
24
0
1
Order By: Relevance
“…11 Phenobarbital is another medication recommended by the World Health Organization for the treatment of certain types of epilepsy in developing countries (Fig. 12 Merbarone was a derivative of barbituric acid and represented a unique class of antineoplastic agents which showed curative activity against L1210 leukemia and also possessed important activity against some other murine tumors ( Fig. 12 Merbarone was a derivative of barbituric acid and represented a unique class of antineoplastic agents which showed curative activity against L1210 leukemia and also possessed important activity against some other murine tumors ( Fig.…”
mentioning
confidence: 99%
“…11 Phenobarbital is another medication recommended by the World Health Organization for the treatment of certain types of epilepsy in developing countries (Fig. 12 Merbarone was a derivative of barbituric acid and represented a unique class of antineoplastic agents which showed curative activity against L1210 leukemia and also possessed important activity against some other murine tumors ( Fig. 12 Merbarone was a derivative of barbituric acid and represented a unique class of antineoplastic agents which showed curative activity against L1210 leukemia and also possessed important activity against some other murine tumors ( Fig.…”
mentioning
confidence: 99%
“…Historically, phenobarbitone has been the mainstay of epilepsy management in SSA, having the advantages of broad spectrum coverage (although with poor efficacy in absence and myoclonic epilepsy) and a simple dosing regimen at a very low cost. In the past decade, the introduction and expansion of drug regulatory activities and enforcement have significantly increased the cost of phenobarbitone and diminished the overall availability, leading to significant negative effects on the treatment of epilepsy, particularly in remote areas where phenobarbitone is the only accessible AED . The disappearance of phenobarbitone further escalates the need for electrodiagnostic insights at the individual and population level in SSA.…”
Section: Discussionmentioning
confidence: 99%
“…The World Health Organization recommends PHB as a fi rst-line medication for partial and generalized tonic-clonic seizures in developing countries. 2 PHB inhibits seizures by potentiation of synaptic inhibition through an action on the GABA A receptor.…”
Section: Discussionmentioning
confidence: 99%
“…1 The World Health Organization recommends PHB as a fi rst-line medication for partial and generalized tonic-clonic seizures in developing countries. 2 The most important adverse effects of PHB are behavioral and cognitive alterations. PHB has been reported, from the early fi fties, to be associated with adverse effects like exfoliative dermatitis, morbilliform or scarlatiniform rash.…”
Section: Introductionmentioning
confidence: 99%